Journal of Allergy and Clinical Immunology
Asthma outcomes: Composite scores of asthma control
Section snippets
Definitions and methodology for measurement
The ATS/ERS statement divided its “Composite Measures of Asthma Control” section into composite measures expressed as (1) categorical variables in which a descriptive category of asthma control is measured (eg, asthma control days/asthma-free days/episode-free days, “well-controlled” asthma weeks/“total control” weeks, or guideline-based categories, including “well controlled,” “not well controlled,” or “poorly controlled” asthma) and (2) numeric variables in which several independent variables
References (86)
- et al.
Development of the asthma control test: a survey for assessing asthma control
J Allergy Clin Immunol
(2004) - et al.
Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire
Respir Med
(2006) - et al.
Development and cross-sectional validation of the Childhood Asthma Control Test
J Allergy Clin Immunol
(2007) - et al.
Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists
J Allergy Clin Immunol
(2006) - et al.
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
Respir Med
(2005) - et al.
The minimally important difference of the Asthma Control Test
J Allergy Clin Immunol
(2009) - et al.
Quantifying asthma symptoms in adults: the Lara Asthma Symptom Scale
J Allergy Clin Immunol
(2007) - et al.
Validity of asthma control test for asthma control assessment in Chinese primary care settings
Chest
(2009) - et al.
The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations
J Allergy Clin Immunol
(2008) - et al.
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease
J Allergy Clin Immunol
(2007)
The relationship between obesity and asthma severity and control in adults
J Allergy Clin Immunol
Using an asthma control questionnaire and administrative data to predict health-care utilization
Chest
Impact of asthma controller medications on clinical, economic, and patient-reported outcomes
Mayo Clin Proc
Validation of a single survey that can be used for case identification and assessment of asthma control: the Breathmobile Program
Ann Allergy Asthma Immunol
Initial test of the seattle asthma severity and control questionnaire: a multidimensional assessment of asthma severity and control
Ann Allergy Asthma Immunol
Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children
J Allergy Clin Immunol
Emotional quality-of-life and outcomes in adolescents with asthma
J Pediatr
How should we quantify asthma control? A proposal
Chest
The impact of inadequately controlled asthma in urban children on quality of life and productivity
Ann Allergy Asthma Immunol
Clinical profile, health-related quality of life, and asthma control in children attending US asthma camps
Ann Allergy Asthma Immunol
Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting
Chest
Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use?
Respir Med
Validation of the Spanish version of the Asthma Control Questionnaire
Clin Ther
Concordance between supervised and postal administration of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ) was very high
J Clin Epidemiol
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study
Ann Allergy Asthma Immunol
Close correlation between anxiety, depression, and asthma control
Respir Med
Predicting asthma control using patient attitudes toward medical care: the REACT score
Ann Allergy Asthma Immunol
Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide
Ann Allergy Asthma Immunol
Influence of patients’ characteristics and disease management on asthma control
J Allergy Clin Immunol
Asthma patients’ perception of their ability to influence disease control and management
Ann Allergy Asthma Immunol
Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey
J Allergy Clin Immunol
Reliability and factor analysis of the Spanish version of the asthma control test
Ann Allergy Asthma Immunol
Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology
J Allergy Clin Immunol
Relationship of the asthma control test with pulmonary function and exhaled nitric oxide
Ann Allergy Asthma Immunol
Quality of care for childhood asthma: estimating impact and implications
Pediatrics
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice
Am J Respir Crit Care Med
Measuring asthma control: a comparison of three classification systems
Eur Respir J
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma, Full Report 2007. Bethesda (MD): US Department of Health and Human Services
Development and validation of a questionnaire to measure asthma control
Eur Respir J
The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents
Dis Manag
Quantification of asthma control: validation of the Asthma Control Scoring System
Allergy
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007
J Allergy Clin Immunol
Health measurement scales: a practical guide to their development and use
Cited by (0)
The Asthma Outcomes workshop was funded by contributions from the National Institute of Allergy and Infectious Diseases; the National Heart, Lung, and Blood Institute; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Institute of Environmental Health Sciences; the Agency for Healthcare Research and Quality; and the Merck Childhood Asthma Network, as well as by a grant from the Robert Wood Johnson Foundation. Contributions from the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Institute of Environmental Health Sciences, and the US Environmental Protection Agency funded the publication of this article and all other articles in this supplement.
Disclosure of potential conflict of interest: M. Schatz has consulted for Amgen and has received research support from Aerocrine, GlaxoSmithKline, Merck, and Genentech. M. Castro has received consulting and speaker fees from Asthmatx; is a speaker and is on the advisory board for Genentech; is a speaker for AstraZeneca, Merck, and GlaxoSmithKline; has received royalties from Elsevier; and has received research support from Asthmatx, Amgen, Ception/Cephalon, Genentech, MedImmune, Merck, Novartis, the NIH, and GlaxoSmithKline. J. R. Sheller has received research support from Actelion Pharmaceuticals. S. W. Stoloff is Chairman of the Allergy and Asthma Network Mothers of Asthmatics Board. The rest of the authors declare that they have no relevant conflicts of interest.